Bone turnover markers associated with cognitive dysfunction in patients undergoing hemodialysis: a cross-sectional study
Open Access
- 5 August 2026
- journal article
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 10 (10)
Abstract
Cognitive impairment is common in patients undergoing hemodialysis; however, evidence linking routinely measured bone turnover markers to cognition remains limited. In this exploratory cross-sectional study, we aimed to evaluate whether bone-specific alkaline phosphatase (BAP), total alkaline phosphatase (ALP), and tartrate-resistant acid phosphatase 5b (TRACP-5b) are related to global cognitive function in older patients undergoing hemodialysis. Adults aged ≥65 yr receiving maintenance hemodialysis were enrolled at seven centers in Tokyo and Chiba, Japan (November 2021-November 2022). Global cognition was assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). Multivariable linear regression with robust SEs and facility fixed effects was used to examine associations with MoCA scores across sequentially adjusted models. Because of a ceiling effect, MMSE was analyzed using logistic regression with MMSE ≤23 as the outcome (unadjusted and age-/sex-adjusted). For statistical analyses, bone turnover markers were natural log-transformed. Among 380 participants (median age 74 yr; 67.6% male), higher BAP was consistently associated with lower MoCA scores (fully adjusted β −1.03; 95% CI, −1.90 to −0.16). Total ALP showed inverse associations in less-adjusted models; however, these associations attenuated after full adjustment (β −.88; 95% CI, −1.89 to 0.14). TRACP-5b was not clearly associated with MoCA scores. Higher BAP and total ALP were associated with higher odds of MMSE-defined cognitive dysfunction, whereas TRACP-5b was not. These findings suggest a potential association between bone formation-related markers and cognitive performance in older patients undergoing hemodialysis. Prospective and mechanistic studies are warranted to clarify causality and clinical utility.Keywords
Funding Information
- Jikei University Research Fund for Graduate Students
- Jikei University Graduate Research Fund
- Tsuchiya Foundation
- JSPS KAKENHI (20K17259)
- JSPS KAKENHI (23K07727)
- Grant for Pathophysiological Research Conference in Chronic Kidney Disease from The Kidney Foundation (JKFB21-15)
- Grant for Pathophysiological Research Conference in Chronic Kidney Disease from The Kidney Foundation (JKFB23-7)
This publication has 41 references indexed in Scilit:
- Association between serum magnesium levels and cognitive function in patients undergoing hemodialysisClinical and Experimental Nephrology, 2024
- Serum alkaline phosphatase is a strong predictor of mortality in ESKD patients: analysis of the RISCAVID cohortJournal Of Nephrology, 2024
- Roles of PTH and FGF23 in kidney failure: a focus on nonclassical effectsClinical and Experimental Nephrology, 2023
- Serum alkaline phosphatase and infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-cohort studyClinical and Experimental Nephrology, 2022
- Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPSJournal of Cachexia, Sarcopenia and Muscle, 2021
- Elevated serum alkaline phosphatase as a predictor of cognitive impairment in patients with acute ischaemic stroke: A retrospective cohort studyArchives of Gerontology and Geriatrics, 2020
- Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 projectAging Clinical and Experimental Research, 2020
- Principles of confounder selectionEuropean Journal of Epidemiology, 2019
- A re‐examination of Montreal Cognitive Assessment (MoCA) cutoff scoresInternational Journal of Geriatric Psychiatry, 2017
- “Mini-mental state”Journal of Psychiatric Research, 1975